As head of biomarkers and molecular imaging at Charles River Discovery Services, Finland, Tuulia Huhtala works to discover and advance applications of nuclear imaging solutions in drug development, specifically in the fields of CNS and oncological research. With broad experience in imaging, disease models, and ex vivo biomolecule analysis, she has contributed to 20 publications in peer-reviewed journals.
After establishing Charles River’s nuclear imaging unit, her team merged with the site’s biomarker team. Studying bioscientific chemistry, Tuulia received her MSc and PhD in the University of Eastern Finland.
Articles
- Cell Population Analysis as a Biomarket (Eureka Blog)
- Watching How Tumors Progress (Eureka Blog)